Identification	O	NOUN	B
of	O	ADP	O
APC2	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
homologue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
tumour	I-Disease	NOUN	O
suppressor	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
colon	B-Disease	NOUN	B
carcinoma	I-Disease	NOUN	I
cells	O	NOUN	O
,	O	PUNCT	O
loss	O	NOUN	B
of	O	ADP	O
APC	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
betacatenin	O	NOUN	B
in	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
it	O	PRON	O
binds	O	VERB	B
to	O	PART	O
and	O	CCONJ	O
activates	O	VERB	B
the	O	DET	O
Tcf	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	B
transcription	O	NOUN	I
factor	O	NOUN	I
(	O	PUNCT	O
reviewed	O	VERB	B
in	O	ADP	O
[	O	PUNCT	O
1	O	NUM	O
]	O	PUNCT	O
[	O	PUNCT	O
2	O	NUM	O
]	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
MSH2	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
English	O	PROPN	B
and	O	CCONJ	O
North	O	ADJ	B
American	O	ADJ	I
HNPCC	B-Disease	NOUN	B
families	O	NOUN	B
:	O	PUNCT	O
origin	O	NOUN	B
,	O	PUNCT	O
phenotypic	O	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
sex	O	NOUN	B
specific	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
this	O	DET	O
mutation	O	NOUN	B
was	O	AUX	O
initially	O	ADV	O
detected	O	VERB	B
in	O	ADP	O
four	O	NUM	O
of	O	ADP	O
33	O	NUM	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
families	O	NOUN	B
analysed	O	VERB	B
from	O	ADP	O
eastern	O	ADJ	B
England	O	PROPN	I
,	O	PUNCT	O
more	O	ADV	O
extensive	O	ADJ	O
analysis	O	NOUN	B
has	O	AUX	O
reduced	O	VERB	B
the	O	DET	O
frequency	O	NOUN	B
to	O	PART	O
four	O	NUM	O
of	O	ADP	O
52	O	NUM	O
(	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
English	O	ADJ	B
HNPCC	B-Disease	NOUN	B
kindreds	O	NOUN	B
analysed	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
MSH2	O	NOUN	B
mutation	O	NOUN	B
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
10	O	NUM	O
of	O	ADP	O
20	O	NUM	O
(	O	PUNCT	O
50	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
separately	O	ADV	O
identified	O	VERB	B
colorectal	B-Disease	ADJ	B
families	O	NOUN	I
from	O	ADP	O
Newfoundland	O	PROPN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggested	O	VERB	O
a	O	DET	O
founder	O	NOUN	B
effect	O	NOUN	B
within	O	ADP	O
Newfoundland	O	NOUN	B
similar	O	ADJ	O
to	O	ADP	O
that	O	DET	O
reported	O	VERB	O
by	O	ADP	O
others	O	NOUN	O
for	O	ADP	O
two	O	NUM	O
MLH1	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
Finnish	O	ADJ	B
HNPCC	B-Disease	NOUN	B
families	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
was	O	AUX	O
significantly	O	ADV	B
higher	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
males	O	NOUN	B
than	O	ADP	O
females	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
63	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
30	O	NUM	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
84	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
44	O	NUM	O
at	O	ADP	O
ages	O	NOUN	B
50	O	NUM	O
and	O	CCONJ	O
60	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


For	O	ADP	O
females	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
high	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
endometrial	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
at	O	ADP	O
age	O	NOUN	B
60	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
premenopausal	B-Disease	ADJ	B
ovarian	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
at	O	ADP	O
50	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Age	O	NOUN	B
of	O	ADP	O
onset	O	NOUN	O
(	O	PUNCT	O
AO	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Huntington	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
HD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
length	O	NOUN	B
of	O	ADP	O
an	O	DET	O
expanded	O	VERB	O
CAG	O	NOUN	B
repeat	O	NOUN	I
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
determined	O	VERB	O
APOE	O	ADJ	B
genotype	O	NOUN	B
and	O	CCONJ	O
normal	O	ADJ	O
CAG	O	NOUN	B
repeat	O	NOUN	I
length	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
for	O	ADP	O
138	O	NUM	O
HD	B-Disease	NOUN	B
patients	O	NOUN	B
who	O	PRON	O
were	O	AUX	O
previously	O	ADV	O
analysed	O	VERB	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
CAG	O	NOUN	B
repeat	O	NOUN	I
length	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
highlighting	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
repeat	O	NOUN	I
length	O	NOUN	B
upon	O	SCONJ	O
AO	O	NOUN	B
in	O	ADP	O
maternally	O	ADV	B
inherited	O	VERB	I
HD	B-Disease	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
male	O	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
APOE	O	NOUN	B
epsilon2epsilon3	O	NOUN	O
genotype	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
significantly	O	ADV	O
earlier	O	ADJ	O
AO	O	PROPN	B
in	O	ADP	O
males	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
females	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
serum	O	NOUN	B
of	O	ADP	O
a	O	DET	O
29	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
old	O	ADJ	O
woman	O	NOUN	B
with	O	ADP	O
a	O	DET	O
recent	O	ADJ	O
episode	O	NOUN	B
of	O	ADP	O
disseminated	B-Disease	ADJ	B
gonococcal	I-Disease	ADJ	B
infection	I-Disease	NOUN	I
and	O	CCONJ	O
a	O	DET	O
history	O	NOUN	B
of	O	ADP	O
meningococcal	B-Disease	ADJ	B
meningitis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
as	O	ADP	O
a	O	DET	O
child	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
lack	O	VERB	O
serum	O	NOUN	B
hemolytic	O	ADJ	O
complement	O	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


Complete	B-Disease	ADJ	B
absence	I-Disease	NOUN	B
of	I-Disease	ADP	O
C7	I-Disease	NOUN	B
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
in	O	ADP	O
one	O	NUM	O
sibling	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
the	O	DET	O
clinical	O	ADJ	B
syndrome	O	NOUN	I
of	O	ADP	O
meningococcal	B-Disease	ADJ	B
meningitis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
as	O	ADP	O
a	O	DET	O
child	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
this	O	DET	O
siblings	O	NOUN	B
clinically	O	ADV	B
well	O	ADV	O
eight	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
son	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
represents	O	VERB	O
the	O	DET	O
first	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
C7	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
associated	O	VERB	B
with	O	ADP	I
infectious	O	ADJ	B
complications	O	NOUN	I
and	O	CCONJ	O
suggests	O	VERB	O
that	O	SCONJ	O
bactericidal	O	ADJ	B
activity	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
host	O	NOUN	B
defense	O	NOUN	B
against	O	ADP	O
bacteremic	B-Disease	ADJ	B
neisseria	I-Disease	NOUN	O
infections	I-Disease	NOUN	O
.	O	PUNCT	O


Increased	O	VERB	B
incidence	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
cartilage	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
hair	I-Disease	NOUN	B
hypoplasia	I-Disease	NOUN	I
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
was	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
to	O	PART	O
further	O	ADV	O
evaluate	O	VERB	B
this	O	DET	O
risk	O	NOUN	B
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
first	O	ADJ	B
-	O	PUNCT	O
degree	O	NOUN	B
relatives	O	NOUN	O
.	O	PUNCT	O


RESULTS	O	VERB	B
A	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
excess	O	ADJ	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
was	O	AUX	O
seen	O	VERB	O
among	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
(	O	PUNCT	O
standardized	O	ADJ	B
incidence	O	NOUN	I
ratio	O	NOUN	I
6	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
confidence	O	NOUN	B
interval	O	NOUN	I
2	O	NUM	I
.	O	PUNCT	O
3	O	NUM	O
to	O	PART	O
16	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
mainly	O	ADV	O
attributable	O	ADJ	O
to	O	PART	O
non	B-Disease	ADV	B
-	I-Disease	PUNCT	O
Hodgkins	I-Disease	NOUN	B
lymphoma	I-Disease	NOUN	I
(	O	PUNCT	O
standardized	O	ADJ	B
incidence	O	NOUN	I
ratio	O	NOUN	I
90	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
confidence	O	NOUN	B
interval	O	NOUN	I
18	O	NUM	O
to	O	PART	O
264	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
among	O	ADP	O
the	O	DET	O
siblings	O	NOUN	B
or	O	CCONJ	O
the	O	DET	O
parents	O	NOUN	B
did	O	AUX	O
not	O	PART	O
differ	O	VERB	O
from	O	ADP	O
the	O	DET	O
average	O	ADJ	B
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Finnish	O	ADJ	B
population	O	NOUN	B
.	O	PUNCT	O


Genotype	O	NOUN	B
and	O	CCONJ	O
phenotype	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
dihydropyrimidine	B-Disease	NOUN	B
dehydrogenase	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
and	O	CCONJ	O
phenotypic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
DPD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
reviewed	O	VERB	B
17	O	NUM	O
families	O	NOUN	B
presenting	O	VERB	O
22	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
complete	O	ADJ	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
DPD	I-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
large	O	ADJ	O
phenotypic	O	ADJ	B
variability	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
convulsive	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
motor	B-Disease	NOUN	B
retardation	I-Disease	NOUN	I
and	O	CCONJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
being	O	AUX	O
the	O	DET	O
most	O	ADV	O
abundant	O	ADJ	B
manifestations	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
altered	O	ADJ	O
beta	O	NOUN	B
-	O	PUNCT	O
alanine	O	NOUN	B
,	O	PUNCT	O
uracil	O	NOUN	B
and	O	CCONJ	O
thymine	O	NOUN	B
homeostasis	O	NOUN	B
might	O	AUX	O
underlie	O	VERB	O
the	O	DET	O
various	O	ADJ	O
clinical	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
encountered	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
DPD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


Borjeson	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Forssman	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Lehmann	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
BFLS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
syndromal	O	ADJ	B
X	B-Disease	NOUN	I
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
mental	I-Disease	ADJ	B
retardation	I-Disease	NOUN	I
,	O	PUNCT	O
which	O	DET	O
maps	O	VERB	B
by	O	ADP	O
linkage	O	NOUN	B
to	O	PART	O
the	O	DET	O
q26	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
X	O	NOUN	O
chromosome	O	NOUN	O
.	O	PUNCT	O


Germline	O	NOUN	B
E	O	PROPN	I
-	O	PUNCT	O
cadherin	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
CDH1	O	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
predispose	O	VERB	O
to	O	PART	O
familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
and	O	CCONJ	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Inherited	O	VERB	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
E	O	PROPN	B
-	O	PUNCT	O
cadherin	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
CDH1	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
described	O	VERB	O
recently	O	ADV	O
in	O	ADP	O
three	O	NUM	O
Maori	O	ADJ	B
kindreds	O	NOUN	B
with	O	ADP	O
familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Each	O	DET	O
family	O	NOUN	B
contained	O	VERB	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
two	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
in	O	ADP	O
first	O	ADJ	O
degree	O	NOUN	O
relatives	O	NOUN	O
with	O	ADP	O
one	O	NUM	O
affected	O	VERB	B
before	O	ADP	O
age	O	NOUN	B
50	O	NUM	O
years	O	NOUN	B
;	O	PUNCT	O
or	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
three	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
one	O	NUM	O
family	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
evidence	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
penetrance	O	NOUN	B
and	O	CCONJ	O
susceptibility	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
gastric	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
colorectal	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
;	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
six	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
a	O	DET	O
CDH1	O	NOUN	B
mutation	O	NOUN	B
carrier	O	NOUN	I
developed	O	VERB	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
at	O	ADP	O
age	O	NOUN	B
30	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
only	O	ADV	O
a	O	DET	O
minority	O	NOUN	B
of	O	ADP	O
familial	O	ADJ	B
gastric	B-Disease	ADJ	I
cancers	I-Disease	NOUN	I
can	O	AUX	O
be	O	AUX	O
accounted	O	VERB	O
for	O	ADP	O
by	O	ADP	O
CDH1	O	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
zinc	O	NOUN	B
finger	O	NOUN	I
truncation	O	NOUN	B
of	O	ADP	O
murine	O	ADJ	B
WT1	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
characteristic	O	ADJ	B
urogenital	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
of	O	ADP	O
Denys	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Drash	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Wilms	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
-	O	PUNCT	O
suppressor	O	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
WT1	O	NOUN	B
,	O	PUNCT	O
plays	O	VERB	O
a	O	DET	O
key	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
urogenital	O	ADJ	B
development	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
WT1	B-Disease	NOUN	B
dysfunction	I-Disease	NOUN	O
is	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
both	O	CCONJ	O
neoplastic	B-Disease	ADJ	B
(	O	PUNCT	O
Wilms	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
,	O	PUNCT	O
mesothelioma	B-Disease	NOUN	B
,	O	PUNCT	O
leukemias	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
nonneoplastic	B-Disease	ADJ	B
(	O	PUNCT	O
glomerulosclerosis	B-Disease	NOUN	O
)	O	PUNCT	O
disease	O	NOUN	O
.	O	PUNCT	O


DDS	B-Disease	NOUN	B
patients	O	NOUN	B
are	O	AUX	O
constitutionally	O	ADV	O
heterozygous	O	ADJ	B
for	O	ADP	O
exonic	O	ADJ	B
point	O	NOUN	I
mutations	O	NOUN	I
in	O	ADP	O
WT1	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
include	O	VERB	O
mutations	O	NOUN	B
predicted	O	VERB	O
to	O	PART	O
truncate	O	VERB	O
the	O	DET	O
protein	O	NOUN	B
within	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
zinc	O	NOUN	B
finger	O	NOUN	I
(	O	PUNCT	O
ZF	O	NOUN	O
)	O	PUNCT	O
region	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
heterozygosity	O	NOUN	B
for	O	ADP	O
a	O	DET	O
targeted	O	VERB	O
murine	O	ADJ	B
Wt1	O	NOUN	B
allele	O	NOUN	B
,	O	PUNCT	O
Wt1	O	NOUN	B
(	O	PUNCT	O
tmT396	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
truncates	O	VERB	B
ZF3	O	NOUN	B
at	O	ADP	O
codon	O	NOUN	B
396	O	NUM	I
,	O	PUNCT	O
induces	O	VERB	O
mesangial	B-Disease	ADJ	B
sclerosis	I-Disease	NOUN	I
characteristic	O	NOUN	O
of	O	ADP	O
DDS	B-Disease	NOUN	B
in	O	ADP	O
adult	O	ADJ	B
heterozygous	O	ADJ	B
and	O	CCONJ	O
chimeric	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Mechanism	O	NOUN	B
of	O	ADP	O
increased	O	VERB	B
iron	O	NOUN	B
absorption	O	NOUN	I
in	O	ADP	O
murine	O	ADJ	B
model	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
:	O	PUNCT	O
increased	O	VERB	B
duodenal	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
iron	O	NOUN	B
transporter	O	NOUN	I
DMT1	O	NOUN	B
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
HH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
characterized	O	VERB	B
by	O	ADP	O
tissue	O	NOUN	B
iron	O	NOUN	B
deposition	O	NOUN	I
secondary	O	ADJ	B
to	O	PART	I
excessive	O	ADJ	B
dietary	O	ADJ	B
iron	O	NOUN	O
absorption	O	NOUN	O
.	O	PUNCT	O


Neurophysiologic	O	ADJ	B
follow	O	NOUN	B
-	O	PUNCT	O
up	O	NOUN	O
of	O	ADP	O
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
dietary	O	ADJ	B
treatment	O	NOUN	I
in	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
adrenoleukodystrophy	B-Disease	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
To	O	PART	O
monitor	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
dietary	O	ADJ	B
treatment	O	NOUN	I
in	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
adrenoleukodystrophy	B-Disease	NOUN	I
(	O	PUNCT	O
ALD	B-Disease	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
somatosensory	O	ADJ	B
evoked	O	VERB	I
potentials	O	NOUN	I
(	O	PUNCT	O
SEPs	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
motor	O	NOUN	B
evoked	O	VERB	I
potentials	O	NOUN	I
(	O	PUNCT	O
MEPs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


METHODS	O	VERB	O
Eight	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
ALD	B-Disease	NOUN	B
underwent	O	VERB	O
clinical	O	ADJ	B
examination	O	NOUN	I
,	O	PUNCT	O
brain	O	NOUN	B
and	O	CCONJ	O
spine	O	NOUN	B
MRI	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
SEP	O	PROPN	B
and	O	CCONJ	O
MEP	O	PROPN	B
studies	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
3	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
Lorenzos	O	PROPN	B
oil	O	NOUN	I
dietary	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
treatment	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
three	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
pure	O	ADJ	O
spinal	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
showed	O	VERB	O
clinical	O	ADJ	B
and	O	CCONJ	O
neurophysiologic	O	ADJ	B
worsening	O	NOUN	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
more	O	ADV	O
advanced	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
disease	O	NOUN	O
(	O	PUNCT	O
exhibited	O	VERB	O
by	O	ADP	O
SEPs	O	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
substantially	O	ADV	O
unchanged	O	ADJ	B
clinical	O	ADJ	B
and	O	CCONJ	O
neurophysiologic	O	ADJ	B
features	O	NOUN	B
.	O	PUNCT	O


GCH1	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
oromandibular	B-Disease	ADJ	B
dystonia	I-Disease	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
GCH1	O	NOUN	B
mutations	O	NOUN	B
must	O	AUX	O
be	O	AUX	O
considered	O	VERB	O
even	O	ADV	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
dystonic	B-Disease	ADJ	B
symptoms	O	NOUN	I
not	O	PART	O
typical	O	ADJ	O
of	O	ADP	O
dopa	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
responsive	I-Disease	ADJ	B
dystonia	I-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
extensively	O	ADV	O
analyzed	O	VERB	O
genomic	O	ADJ	B
DNA	O	NOUN	I
and	O	CCONJ	O
messenger	O	NOUN	B
RNA	O	NOUN	I
(	O	PUNCT	O
mRNA	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
62	O	NUM	O
unrelated	O	ADJ	O
Korean	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
(	O	PUNCT	O
FAP	B-Disease	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
identification	O	NOUN	B
of	O	ADP	O
germline	O	NOUN	B
adenomatous	B-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
(	O	PUNCT	O
APC	B-Disease	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
mutations	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
confirm	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mutation	O	NOUN	B
detection	O	NOUN	O
rate	O	NOUN	B
with	O	ADP	O
PTT	O	PROPN	B
was	O	AUX	O
superior	O	ADJ	O
to	O	PART	O
that	O	DET	O
with	O	ADP	O
SSCP	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
PTT	O	PROPN	B
would	O	AUX	O
be	O	AUX	O
a	O	DET	O
more	O	ADV	O
practical	O	ADJ	O
screening	O	NOUN	B
method	O	NOUN	I
to	O	PART	O
detect	O	VERB	B
germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
FAP	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
ninth	I-Disease	ADJ	O
component	I-Disease	NOUN	B
of	I-Disease	ADP	O
human	I-Disease	ADJ	B
complement	I-Disease	NOUN	O
(	O	PUNCT	O
C9	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
complement	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
in	O	ADP	O
Japan	O	PROPN	B
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
one	O	NUM	O
homozygote	O	NOUN	B
in	O	ADP	O
1000	O	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
very	O	ADV	O
rare	O	ADJ	O
in	O	ADP	O
other	O	ADJ	O
countries	O	NOUN	B
.	O	PUNCT	O


Genetic	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
Japanese	O	ADJ	B
C9	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
C	O	PROPN	B
-	O	PUNCT	O
to	O	ADP	O
-	O	PUNCT	O
T	O	NOUN	B
transition	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
TGA	O	NOUN	B
stop	O	VERB	I
codon	O	NOUN	B
for	O	ADP	O
Arg95	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
4	O	NUM	I
of	O	ADP	O
the	O	DET	O
C9	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
Arg95Stop	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
common	O	ADJ	O
in	O	ADP	O
Japanese	O	ADJ	B
C9	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


HFE	O	NOUN	B
is	O	AUX	O
the	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
mutated	O	VERB	I
in	O	ADP	O
the	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disease	I-Disease	NOUN	I
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
Feder	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O


Mutation	O	NOUN	B
and	O	CCONJ	O
haplotype	O	NOUN	B
studies	O	NOUN	B
of	O	ADP	O
familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	B
fever	I-Disease	NOUN	I
reveal	O	VERB	O
new	O	ADJ	O
ancestral	O	ADJ	B
relationships	O	NOUN	B
and	O	CCONJ	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
high	O	ADJ	B
carrier	O	NOUN	I
frequency	O	NOUN	O
with	O	ADP	O
reduced	O	VERB	B
penetrance	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recessive	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
episodes	O	NOUN	B
of	O	ADP	O
fever	O	NOUN	B
with	O	ADP	O
serositis	B-Disease	NOUN	B
or	O	CCONJ	O
synovitis	B-Disease	NOUN	B
.	O	PUNCT	O


Consistent	O	ADJ	B
with	O	ADP	I
another	O	DET	O
recent	O	ADJ	O
report	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
E148Q	O	NOUN	B
mutation	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
ethnicities	O	NOUN	B
and	O	CCONJ	O
on	O	ADP	O
multiple	O	ADJ	B
microsatellite	O	NOUN	B
haplotypes	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
haplotype	O	NOUN	B
data	O	NOUN	B
indicate	O	VERB	O
an	O	DET	O
ancestral	O	ADJ	B
relationships	O	NOUN	B
between	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
Jewish	O	ADJ	B
Italian	O	ADJ	B
and	O	CCONJ	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
FMF	B-Disease	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
affected	O	VERB	B
populations	O	NOUN	B
.	O	PUNCT	O


Autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
disorder	B-Disease	NOUN	B
of	I-Disease	ADP	O
lymphocyte	I-Disease	NOUN	B
homeostasis	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
immunological	I-Disease	ADJ	B
tolerance	I-Disease	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
Fas	O	NOUN	B
variants	O	NOUN	B
,	O	PUNCT	O
not	O	PART	O
restricted	O	ADJ	O
to	O	PART	O
patients	O	NOUN	B
with	O	ADP	O
ALPS	B-Disease	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
ALPS	B-Disease	NOUN	B
-	O	PUNCT	O
associated	O	VERB	B
Fas	O	NOUN	B
mutants	O	NOUN	B
,	O	PUNCT	O
dominant	O	ADJ	B
inhibition	O	NOUN	B
of	O	ADP	O
apoptosis	O	NOUN	B
was	O	AUX	O
much	O	ADV	O
more	O	ADV	O
pronounced	O	ADJ	O
in	O	ADP	O
mutants	O	NOUN	B
affecting	O	VERB	B
the	O	DET	O
intracellular	O	ADJ	B
,	O	PUNCT	O
versus	O	CCONJ	O
extracellular	O	ADJ	B
,	O	PUNCT	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Fas	O	NOUN	B
receptor	O	NOUN	I
.	O	PUNCT	O


Significant	O	ADJ	B
ALPS	B-Disease	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
morbidity	O	NOUN	B
occurred	O	VERB	O
in	O	ADP	O
44	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
relatives	O	NOUN	B
with	O	ADP	O
intracellular	O	ADJ	B
mutations	O	NOUN	B
,	O	PUNCT	O
versus	O	CCONJ	O
0	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
relatives	O	NOUN	B
with	O	ADP	O
extracellular	O	ADJ	B
mutations	O	NOUN	I
.	O	PUNCT	O


Genetic	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
GH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
disease	O	NOUN	B
restricted	O	ADJ	B
to	O	PART	O
those	O	DET	O
of	O	ADP	O
European	O	ADJ	B
ancestry	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
GH	B-Disease	NOUN	B
patients	O	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
mutations	O	NOUN	B
are	O	AUX	O
present	O	ADJ	O
,	O	PUNCT	O
C282Y	O	NOUN	B
and	O	CCONJ	O
H63D	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
selection	O	NOUN	B
pressures	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
due	O	ADJ	O
to	O	PART	O
infectious	B-Disease	ADJ	B
diseases	I-Disease	NOUN	I
,	O	PUNCT	O
environmental	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
other	O	ADJ	O
genetic	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
such	O	ADJ	O
as	O	ADP	O
anemia	B-Disease	NOUN	B
.	O	PUNCT	O


Alkaptonuria	B-Disease	NOUN	B
(	O	PUNCT	O
aku	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
inborn	B-Disease	ADJ	B
error	I-Disease	NOUN	I
of	I-Disease	ADP	O
metabolism	I-Disease	NOUN	B
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
homogentisate	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
dioxygenase	O	NOUN	B
(	O	PUNCT	O
HGD	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
in	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
model	O	NOUN	I
created	O	VERB	O
by	O	ADP	O
ethylnitrosourea	O	NOUN	B
mutagenesis	O	NOUN	I
but	O	CCONJ	O
the	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
mice	O	NOUN	B
has	O	AUX	O
not	O	PART	O
previously	O	ADV	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Enlarged	B-Disease	ADJ	B
vestibular	I-Disease	ADJ	I
aqueduct	I-Disease	NOUN	I
(	O	PUNCT	O
EVA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
known	O	VERB	O
as	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
inner	B-Disease	ADJ	B
ear	I-Disease	NOUN	I
abnormality	I-Disease	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
of	O	ADP	O
particular	O	ADJ	O
genetic	O	ADJ	B
interest	O	NOUN	O
because	O	SCONJ	O
this	O	DET	O
anomaly	O	NOUN	B
is	O	AUX	O
inherited	O	VERB	B
in	O	ADP	O
a	O	DET	O
recessive	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
seven	O	NUM	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
PDS	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
in	O	ADP	O
families	O	NOUN	B
of	O	ADP	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
sensorineural	I-Disease	ADJ	O
hearing	I-Disease	NOUN	O
loss	I-Disease	NOUN	O
with	O	ADP	O
EVA	B-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
results	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
PDS	O	PROPN	B
cause	O	VERB	O
both	O	CCONJ	O
syndromic	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
non	I-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
classic	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
ALD	B-Disease	NOUN	B
usually	O	ADV	O
has	O	AUX	O
onset	O	NOUN	O
in	O	ADP	O
childhood	O	NOUN	O
(	O	PUNCT	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
rapid	O	ADJ	O
neurologic	B-Disease	ADJ	B
deterioration	I-Disease	NOUN	B
leading	O	VERB	O
to	O	PART	O
a	O	DET	O
vegetative	O	ADJ	B
state	O	NOUN	I
.	O	PUNCT	O


Adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
also	O	ADV	O
presents	O	VERB	O
with	O	ADP	O
rapidly	O	ADV	O
progressive	O	ADJ	B
neurologic	B-Disease	ADJ	B
dysfunction	I-Disease	NOUN	I
.	O	PUNCT	O


METHODS	O	NOUN	O
The	O	DET	O
29	O	NUM	O
patients	O	NOUN	B
comprised	O	VERB	O
13	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
11	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
5	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adrenomyeloneuropathy	B-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
conducted	O	VERB	O
detailed	O	ADJ	O
mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
29	O	NUM	O
unrelated	O	ADJ	O
Japanese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
ALD	B-Disease	NOUN	B
by	O	ADP	O
genomic	O	ADJ	B
Southern	O	NOUN	I
blot	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
direct	O	ADJ	B
nucleotide	O	NOUN	I
sequence	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
reverse	O	ADJ	B
transcriptase	O	NOUN	I
-	O	PUNCT	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
products	O	NOUN	I
derived	O	VERB	O
from	O	ADP	O
total	O	ADJ	O
RNA	O	NOUN	B
that	O	PRON	O
was	O	AUX	O
extracted	O	VERB	O
from	O	ADP	O
cultured	O	VERB	B
skin	O	NOUN	I
fibroblasts	O	NOUN	O
,	O	PUNCT	O
lymphoblastoid	O	ADJ	B
cells	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
peripheral	O	ADJ	B
blood	O	NOUN	I
leukocytes	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
There	O	PRON	O
are	O	AUX	O
no	O	DET	O
obvious	O	ADJ	O
correlations	O	NOUN	B
between	O	ADP	O
the	O	DET	O
phenotypes	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
ALD	B-Disease	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
genotypes	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
genetic	O	ADJ	B
or	O	CCONJ	O
environmental	O	ADJ	B
factors	O	NOUN	I
modify	O	VERB	B
the	O	DET	O
phenotypic	O	ADJ	B
expressions	O	NOUN	B
of	O	ADP	O
ALD	B-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
human	O	ADJ	B
skin	B-Disease	NOUN	B
tumour	I-Disease	NOUN	I
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
activating	O	VERB	B
mutations	O	NOUN	B
in	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
discovered	O	VERB	O
that	O	SCONJ	O
transgenic	O	ADJ	B
mice	O	NOUN	I
expressing	O	VERB	B
an	O	DET	O
activated	O	VERB	B
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
are	O	AUX	O
predisposed	O	VERB	O
to	O	ADP	O
developing	O	VERB	O
skin	B-Disease	NOUN	B
tumours	I-Disease	NOUN	I
resembling	O	VERB	O
pilomatricomas	B-Disease	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
explore	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
origin	O	NOUN	I
and	O	CCONJ	O
aetiology	O	NOUN	B
of	O	ADP	O
this	O	DET	O
common	O	ADJ	O
human	O	ADJ	B
skin	B-Disease	NOUN	B
tumour	I-Disease	NOUN	I
.	O	PUNCT	O


At	O	ADV	O
least	O	ADV	O
75	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
these	O	DET	O
tumours	B-Disease	NOUN	B
possess	O	VERB	O
mutations	O	NOUN	B
affecting	O	VERB	B
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
segment	O	NOUN	B
,	O	PUNCT	O
normally	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
phosphorylation	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
,	O	PUNCT	O
ubiquitin	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
gene	O	NOUN	B
encodes	O	VERB	O
a	O	DET	O
chloride	O	NOUN	B
-	O	PUNCT	O
iodide	O	NOUN	B
transport	O	NOUN	I
protein	O	NOUN	I
.	O	PUNCT	O


Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
syndromic	B-Disease	ADJ	B
deafness	I-Disease	NOUN	I
and	O	CCONJ	O
characterized	O	VERB	B
by	O	ADP	O
congenital	O	ADJ	B
sensorineural	B-Disease	ADJ	I
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
and	O	CCONJ	O
goitre	B-Disease	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
pendrin	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
transporter	O	NOUN	B
of	O	ADP	O
chloride	O	NOUN	B
and	O	CCONJ	O
iodide	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
sulfate	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
thyroid	O	NOUN	B
physiology	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
pathophysiology	O	NOUN	B
of	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
HH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
genetic	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
of	O	ADP	O
iron	O	NOUN	B
metabolism	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
mutations	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
C282Y	O	NOUN	B
,	O	PUNCT	O
accounting	O	VERB	O
for	O	ADP	O
80	O	NUM	O
%	O	NOUN	O
to	O	PART	O
90	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
H63D	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
milder	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
representing	O	VERB	O
40	O	NUM	O
%	O	NOUN	O
to	O	PART	O
70	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
C282Y	O	NOUN	B
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
confirm	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C282Y	O	NOUN	B
substitution	O	NOUN	B
was	O	AUX	O
the	O	DET	O
main	O	ADJ	O
mutation	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
,	O	PUNCT	O
accounting	O	VERB	O
for	O	ADP	O
85	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
carrier	O	NOUN	B
chromosomes	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
H63D	O	NOUN	B
substitution	O	NOUN	B
represented	O	VERB	O
39	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
that	O	PRON	O
did	O	AUX	O
not	O	PART	O
carry	O	VERB	O
the	O	DET	O
C282Y	O	NOUN	B
mutation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
enrichment	O	NOUN	O
of	O	ADP	O
S65C	O	NOUN	B
among	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
S65C	O	NOUN	B
substitution	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
mild	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
.	O	PUNCT	O


To	O	PART	O
achieve	O	VERB	O
this	O	DET	O
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
BRCA1	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
a	O	DET	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
series	O	NOUN	B
of	O	ADP	O
consecutive	O	ADJ	B
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
cases	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
study	O	NOUN	B
reporting	O	VERB	O
BRCA1	O	NOUN	B
alterations	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
comprehensive	O	ADJ	B
screen	O	NOUN	B
of	O	ADP	O
the	O	DET	O
entire	O	ADJ	O
coding	O	VERB	B
region	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
novel	O	ADJ	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
previously	O	ADV	O
reported	O	VERB	O
uncharacterized	O	ADJ	B
variants	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
identified	O	VERB	B
,	O	PUNCT	O
some	O	DET	O
of	O	ADP	O
which	O	DET	O
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	I
cancer	B-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
distribution	O	NOUN	B
of	O	ADP	O
common	O	ADJ	O
polymorphisms	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
the	O	DET	O
91	O	NUM	O
Caucasian	O	ADJ	B
cancer	B-Disease	NOUN	B
cases	O	NOUN	B
in	O	ADP	O
this	O	DET	O
series	O	NOUN	B
and	O	CCONJ	O
24	O	NUM	O
sister	O	NOUN	B
controls	O	NOUN	I
using	O	VERB	O
allele	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
amplification	O	NOUN	B
.	O	PUNCT	O


Adrenoleukodystrophy	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
protein	O	NOUN	B
can	O	AUX	O
compensate	O	VERB	O
functionally	O	ADV	O
for	O	ADP	O
adrenoleukodystrophy	B-Disease	NOUN	B
protein	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
(	O	PUNCT	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	PROPN	B
)	O	PUNCT	O
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
therapy	O	NOUN	B
.	O	PUNCT	O


Inherited	B-Disease	ADJ	B
defects	I-Disease	NOUN	B
in	O	ADP	O
the	O	DET	O
peroxisomal	O	ADJ	B
ATP	O	NOUN	I
-	O	PUNCT	O
binding	O	VERB	B
cassette	O	NOUN	I
(	O	PUNCT	O
ABC	O	NOUN	B
)	O	PUNCT	O
transporter	O	NOUN	O
adrenoleukodystrophy	B-Disease	NOUN	O
protein	O	NOUN	O
(	O	PUNCT	O
ALDP	O	NOUN	B
)	O	PUNCT	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
lethal	O	ADJ	B
peroxisomal	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
adrenoleukodystrophy	I-Disease	NOUN	B
(	O	PUNCT	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
for	O	ADP	O
which	O	DET	O
no	O	DET	O
efficient	O	ADJ	B
treatment	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
established	O	VERB	O
so	O	ADV	O
far	O	ADV	O
.	O	PUNCT	O


Germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Brca1	O	NOUN	B
tumor	B-Disease	NOUN	B
suppressor	O	NOUN	I
gene	O	NOUN	I
predispose	O	VERB	O
women	O	NOUN	B
to	O	ADP	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancers	I-Disease	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
defective	O	ADJ	B
G2	O	NOUN	B
-	O	PUNCT	O
M	O	NOUN	B
checkpoint	O	NOUN	B
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
extensive	O	ADJ	O
chromosomal	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
.	O	PUNCT	O


Defective	O	ADJ	B
CD95	O	NOUN	B
/	O	SYM	O
APO	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
/	O	SYM	O
Fas	O	NOUN	B
signal	O	NOUN	O
complex	O	NOUN	O
formation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
autoimmune	B-Disease	ADJ	I
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
,	I-Disease	PUNCT	O
type	I-Disease	NOUN	B
Ia	I-Disease	NOUN	I
.	O	PUNCT	O


Despite	O	SCONJ	O
heterozygosity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
abnormal	O	ADJ	B
allele	O	NOUN	B
,	O	PUNCT	O
lymphocytes	O	NOUN	B
from	O	ADP	O
ALPS	B-Disease	NOUN	B
patients	O	NOUN	B
showed	O	VERB	O
markedly	O	ADV	O
decreased	O	VERB	B
FADD	O	NOUN	B
association	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
caspase	O	NOUN	B
recruitment	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
after	O	ADP	O
CD95	O	NOUN	B
crosslinking	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
intracytoplasmic	O	ADJ	B
CD95	O	NOUN	B
mutations	O	NOUN	I
in	O	ADP	O
ALPS	B-Disease	NOUN	B
impair	O	VERB	B
apoptosis	O	NOUN	B
chiefly	O	ADV	O
by	O	ADP	O
disrupting	O	VERB	B
death	O	NOUN	B
-	O	PUNCT	O
domain	O	NOUN	B
interactions	O	NOUN	B
with	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
protein	O	NOUN	I
FADD	O	NOUN	B
/	O	SYM	O
MORT1	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Herein	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
haplotype	O	NOUN	B
and	O	CCONJ	O
mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
HGO	O	NOUN	B
in	O	ADP	O
seven	O	NUM	O
new	O	ADJ	O
AKU	B-Disease	NOUN	B
pedigrees	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
analyses	O	NOUN	B
identified	O	VERB	B
two	O	NUM	O
novel	O	ADJ	O
single	O	ADJ	B
-	O	PUNCT	O
nucleotide	O	NOUN	B
polymorphisms	O	NOUN	B
(	O	PUNCT	O
INV4	O	ADJ	B
+	O	CCONJ	O
31A	O	NUM	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
G	O	NOUN	B
and	O	CCONJ	O
INV11	O	NOUN	B
+	O	CCONJ	O
18A	O	PROPN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
G	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
six	O	NUM	O
novel	O	ADJ	O
AKU	B-Disease	NOUN	B
mutations	O	NOUN	B
(	O	PUNCT	O
INV1	O	NOUN	B
-	O	PUNCT	O
1G	O	PROPN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	PROPN	O
A	O	NOUN	O
,	O	PUNCT	O
W60G	O	ADJ	B
,	O	PUNCT	O
Y62C	O	NOUN	O
,	O	PUNCT	O
A122D	O	NOUN	B
,	O	PUNCT	O
P230T	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
D291E	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
further	O	ADV	O
illustrates	O	VERB	O
the	O	DET	O
remarkable	O	ADJ	O
allelic	O	ADJ	B
heterogeneity	O	NOUN	B
found	O	VERB	O
in	O	ADP	O
AKU	B-Disease	PROPN	B
.	O	PUNCT	O


Clinically	O	ADV	B
,	O	PUNCT	O
affected	O	VERB	B
hemizygous	O	ADJ	B
males	O	NOUN	O
have	O	AUX	O
angiokeratoma	B-Disease	NOUN	B
,	O	PUNCT	O
severe	B-Disease	ADJ	B
acroparesthesia	I-Disease	NOUN	I
,	O	PUNCT	O
renal	B-Disease	ADJ	B
failure	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
vasculopathy	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
heart	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
brain	I-Disease	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
chemical	O	ADJ	B
cleavage	O	NOUN	I
of	O	ADP	O
mismatches	O	NOUN	B
adapted	O	VERB	O
to	O	ADP	O
fluorescence	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
detection	O	NOUN	B
systems	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
the	O	DET	O
mutations	O	NOUN	B
underlying	O	VERB	O
alpha	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Gal	I-Disease	NOUN	B
A	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	B
in	O	ADP	O
16	O	NUM	O
individuals	O	NOUN	B
from	O	ADP	O
six	O	NUM	O
unrelated	O	ADJ	O
families	O	NOUN	B
with	O	ADP	O
FD	B-Disease	PROPN	B
.	O	PUNCT	O


Prenatal	O	ADJ	B
diagnosis	O	NOUN	I
by	O	ADP	O
FISH	O	NOUN	B
in	O	ADP	O
a	O	DET	O
family	O	NOUN	B
with	O	ADP	O
Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
duplication	O	NOUN	B
of	O	ADP	O
PLP	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Dominant	O	ADJ	B
negative	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
APC1309	O	NOUN	B
mutation	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
explanation	O	NOUN	O
for	O	ADP	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlations	O	NOUN	B
in	O	ADP	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
familial	B-Disease	ADJ	B
APC	I-Disease	NOUN	O
(	O	PUNCT	O
FAP	B-Disease	NOUN	B
)	O	PUNCT	O
carry	O	VERB	O
germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
develop	O	VERB	O
multiple	O	ADJ	B
colorectal	B-Disease	ADJ	B
adenomas	I-Disease	NOUN	I
and	O	CCONJ	O
subsequent	O	ADJ	O
carcinomas	B-Disease	NOUN	B
early	O	ADV	B
in	O	ADP	O
life	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
severity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
correlates	O	VERB	B
with	O	ADP	O
the	O	DET	O
position	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inherited	O	VERB	B
APC	B-Disease	NOUN	B
mutation	O	NOUN	O
(	O	PUNCT	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlation	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
experimental	O	ADJ	B
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
products	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
severe	O	ADJ	B
polyposis	B-Disease	NOUN	B
.	O	PUNCT	O


Wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
APC	B-Disease	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	PROPN	B
-	O	PUNCT	O
/	O	SYM	O
Tcf	O	PROPN	B
-	O	PUNCT	O
mediated	O	VERB	B
transcription	O	NOUN	B
was	O	AUX	O
strongly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
mutant	O	ADJ	B
APC	B-Disease	NOUN	B
that	O	PRON	O
is	O	AUX	O
truncated	O	VERB	B
at	O	ADP	O
codon	O	NOUN	B
1309	O	NUM	I
.	O	PUNCT	O


Germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
BRCA1	O	NOUN	B
tumor	O	NOUN	B
-	O	PUNCT	O
suppressor	O	NOUN	B
gene	O	NOUN	I
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
increased	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
routine	O	ADJ	O
screening	O	NOUN	B
of	O	ADP	O
sera	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
subject	O	NOUN	B
was	O	AUX	O
discovered	O	VERB	O
who	O	PRON	O
showed	O	VERB	O
a	O	DET	O
sub	B-Disease	ADV	B
-	I-Disease	PUNCT	O
total	I-Disease	ADJ	B
deficiency	I-Disease	NOUN	B
of	I-Disease	ADP	O
C6	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
C7	I-Disease	NOUN	B
.	O	PUNCT	O


Changes	O	NOUN	B
at	O	ADP	O
P183	O	NOUN	B
of	O	ADP	O
emerin	O	NOUN	B
weaken	O	VERB	O
its	O	PRON	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
spanning	O	VERB	O
the	O	DET	O
emerin	O	NOUN	B
gene	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
EDMD	B-Disease	NOUN	B
.	O	PUNCT	O


